Table of Content

1 Influenza Vaccine Market Introduction and Overview
1.1 Influenza Vaccine Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Influenza Vaccine Revenue and Market Share by Manufacturer
2.2 Manufacturers Influenza Vaccine Production Sites, Area Served, Product Types
2.3 Influenza Vaccine Market Competitive Situation and Trends
2.3.1 Influenza Vaccine Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Hualan Bio
3.1.1 Hualan Bio Company Profile
3.1.2 Influenza Vaccine Product Overview
3.1.3 Hualan Bio Influenza Vaccine Market Performance (2019-2024)
3.1.4 Hualan Bio Business Overview
3.2 SANOFI
3.2.1 SANOFI Company Profile
3.2.2 Influenza Vaccine Product Overview
3.2.3 SANOFI Influenza Vaccine Market Performance (2019-2024)
3.2.4 SANOFI Business Overview
3.3 CCBIO
3.3.1 CCBIO Company Profile
3.3.2 Influenza Vaccine Product Overview
3.3.3 CCBIO Influenza Vaccine Market Performance (2019-2024)
3.3.4 CCBIO Business Overview
3.4 Changsheng Biological
3.4.1 Changsheng Biological Company Profile
3.4.2 Influenza Vaccine Product Overview
3.4.3 Changsheng Biological Influenza Vaccine Market Performance (2019-2024)
3.4.4 Changsheng Biological Business Overview
3.5 SINOVAC
3.5.1 SINOVAC Company Profile
3.5.2 Influenza Vaccine Product Overview
3.5.3 SINOVAC Influenza Vaccine Market Performance (2019-2024)
3.5.4 SINOVAC Business Overview
3.6 SIOBP
3.6.1 SIOBP Company Profile
3.6.2 Influenza Vaccine Product Overview
3.6.3 SIOBP Influenza Vaccine Market Performance (2019-2024)
3.6.4 SIOBP Business Overview
3.7 Aleph Biomedical
3.7.1 Aleph Biomedical Company Profile
3.7.2 Influenza Vaccine Product Overview
3.7.3 Aleph Biomedical Influenza Vaccine Market Performance (2019-2024)
3.7.4 Aleph Biomedical Business Overview
3.8 Adimmune
3.8.1 Adimmune Company Profile
3.8.2 Influenza Vaccine Product Overview
3.8.3 Adimmune Influenza Vaccine Market Performance (2019-2024)
3.8.4 Adimmune Business Overview
3.9 ZYAK
3.9.1 ZYAK Company Profile
3.9.2 Influenza Vaccine Product Overview
3.9.3 ZYAK Influenza Vaccine Market Performance (2019-2024)
3.9.4 ZYAK Business Overview
3.10 GSK
3.10.1 GSK Company Profile
3.10.2 Influenza Vaccine Product Overview
3.10.3 GSK Influenza Vaccine Market Performance (2019-2024)
3.10.4 GSK Business Overview
3.11 Aimei Hissen
3.11.1 Aimei Hissen Company Profile
3.11.2 Influenza Vaccine Product Overview
3.11.3 Aimei Hissen Influenza Vaccine Market Performance (2019-2024)
3.11.4 Aimei Hissen Business Overview
3.12 Tianyuan Bio-pharma
3.12.1 Tianyuan Bio-pharma Company Profile
3.12.2 Influenza Vaccine Product Overview
3.12.3 Tianyuan Bio-pharma Influenza Vaccine Market Performance (2019-2024)
3.12.4 Tianyuan Bio-pharma Business Overview
3.13 Simcere Vaxtec
3.13.1 Simcere Vaxtec Company Profile
3.13.2 Influenza Vaccine Product Overview
3.13.3 Simcere Vaxtec Influenza Vaccine Market Performance (2019-2024)
3.13.4 Simcere Vaxtec Business Overview
3.14 Tiantan Biological
3.14.1 Tiantan Biological Company Profile
3.14.2 Influenza Vaccine Product Overview
3.14.3 Tiantan Biological Influenza Vaccine Market Performance (2019-2024)
3.14.4 Tiantan Biological Business Overview
4 Global Influenza Vaccine Historical and Forecast Market Analysis by Type
4.1 Global Influenza Vaccine Revenue and Market Share by Type
4.2 Global Influenza Vaccine Revenue Market Forecast by Type (2024-2030)
5 Global Influenza Vaccine Historical and Forecast Market Analysis by Application
5.1 Global Influenza Vaccine Revenue Market Share by Application (2019-2024)
5.2 Influenza Vaccine Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Influenza Vaccine Market Size & Forecast (2019-2030)
6.2 Influenza Vaccine Growth Trends Analysis by Regions
6.2.1 Influenza Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Influenza Vaccine Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Influenza Vaccine Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.5 Europe Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.6 China Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.7 Japan Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.8 Korea Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.10 India Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.11 South America Influenza Vaccine Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Influenza Vaccine Market Size & Forecast (2019-2030)
7 North America
7.1 North America Influenza Vaccine Revenue by Players
7.2 North America Influenza Vaccine Revenue by Types
7.3 North America Influenza Vaccine Revenue by Applications
7.4 North America Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Influenza Vaccine Revenue by Players
8.2 Europe Influenza Vaccine Revenue by Types
8.3 Europe Influenza Vaccine Revenue by Applications
8.4 Europe Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Influenza Vaccine Revenue by Players
9.2 China Influenza Vaccine Revenue by Types
9.3 China Influenza Vaccine Revenue by Applications
9.4 China Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Influenza Vaccine Revenue by Players
10.2 Japan Influenza Vaccine Revenue by Types
10.3 Japan Influenza Vaccine Revenue by Applications
10.4 Japan Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Influenza Vaccine Revenue by Players
11.2 Korea Influenza Vaccine Revenue by Types
11.3 Korea Influenza Vaccine Revenue by Applications
11.4 Korea Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Influenza Vaccine Revenue by Players
12.2 Southeast Asia Influenza Vaccine Revenue by Types
12.3 Southeast Asia Influenza Vaccine Revenue by Applications
12.4 Southeast Asia Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Influenza Vaccine Revenue by Players
13.2 India Influenza Vaccine Revenue by Types
13.3 India Influenza Vaccine Revenue by Applications
13.4 India Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Influenza Vaccine Revenue by Players
14.2 South America Influenza Vaccine Revenue by Types
14.3 South America Influenza Vaccine Revenue by Applications
14.4 South America Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Influenza Vaccine Revenue by Players
15.2 Middle East & Africa Influenza Vaccine Revenue by Types
15.3 Middle East & Africa Influenza Vaccine Revenue by Applications
15.4 Middle East & Africa Influenza Vaccine Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Influenza Vaccine Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Influenza Vaccine Industrial Chain Analysis
17 Influenza Vaccine Industry Dynamic Analysis
17.1 Influenza Vaccine Market Trends Analysis
17.2 Influenza Vaccine Market Drivers Analysis
17.3 Influenza Vaccine Market Challenges Analysis
17.4 Influenza Vaccine Market Restraints Analysis
18 Research Findings and Conclusion